These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2092997

  • 1. [125I][D-Tyr25,Nle28,31]CCK-(25-33): a convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography.
    Carlberg M, Beart PM, Jarrott B.
    Eur J Pharmacol; 1990 Nov 20; 191(1):107-10. PubMed ID: 2092997
    [Abstract] [Full Text] [Related]

  • 2. Specific binding of D-Tyr25 (Nle28,31)-CCK(25-33) to cortical membranes from rat brain.
    Carlberg M, Jarrott B, Beart PM.
    Neurosci Lett; 1991 Jan 14; 122(1):29-32. PubMed ID: 2057133
    [Abstract] [Full Text] [Related]

  • 3. Autoradiographic Localization of Cholecystokinin A and B Receptors in Rat Brain Using [125I]d-Tyr25 (Nle28,31)-CCK 25 - 33S.
    Carlberg M, Gundlach AL, Mercer LD, Beart PM.
    Eur J Neurosci; 1992 Jan 14; 4(6):563-573. PubMed ID: 12106342
    [Abstract] [Full Text] [Related]

  • 4. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP.
    Mol Pharmacol; 1992 Jun 14; 41(6):1089-95. PubMed ID: 1614411
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia.
    Widdop RE, Krstew E, Mercer LD, Carlberg M, Beart PM, Jarrott B.
    J Auton Nerv Syst; 1994 Jun 14; 46(1-2):65-73. PubMed ID: 8120343
    [Abstract] [Full Text] [Related]

  • 6. Characterization of cholecystokinin binding sites in rat cerebral cortex using a 125I-CCK-8 probe resistant to degradation.
    Praissman M, Martinez PA, Saladino CF, Berkowitz JM, Steggles AW, Finkelstein JA.
    J Neurochem; 1983 May 14; 40(5):1406-13. PubMed ID: 6300335
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.
    Rodriguez M, Amblard M, Galas MC, Lignon MF, Aumelas A, Martinez J.
    Int J Pept Protein Res; 1990 May 14; 35(5):441-51. PubMed ID: 2376470
    [Abstract] [Full Text] [Related]

  • 10. Temperature dependence of high-affinity CCK receptor binding and CCK internalization in rat pancreatic acini.
    Williams JA, Bailey AC, Roach E.
    Am J Physiol; 1988 Apr 14; 254(4 Pt 1):G513-21. PubMed ID: 3354673
    [Abstract] [Full Text] [Related]

  • 11. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand.
    Van Dijk A, Richards JG, Trzeciak A, Gillessen D, Möhler H.
    J Neurosci; 1984 Apr 14; 4(4):1021-33. PubMed ID: 6325601
    [Abstract] [Full Text] [Related]

  • 12. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
    Reubi JC, Schaer JC, Waser B.
    Cancer Res; 1997 Apr 01; 57(7):1377-86. PubMed ID: 9102227
    [Abstract] [Full Text] [Related]

  • 13. Establishment of a new short, protease-resistant, affinity labeling reagent for the cholecystokinin receptor.
    Pearson RK, Powers SP, Hadac EM, Gaisano H, Miller LJ.
    Biochem Biophys Res Commun; 1987 Aug 31; 147(1):346-53. PubMed ID: 2443134
    [Abstract] [Full Text] [Related]

  • 14. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES, McQuade J, Moran TH, Smith GP.
    Brain Res; 1993 Sep 24; 623(1):161-6. PubMed ID: 8221086
    [Abstract] [Full Text] [Related]

  • 15. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D.
    Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ.
    Mol Pharmacol; 1989 Jun 01; 35(6):803-8. PubMed ID: 2733696
    [Abstract] [Full Text] [Related]

  • 17. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.
    Reubi JC, Waser B, Schaer JC, Laederach U, Erion J, Srinivasan A, Schmidt MA, Bugaj JE.
    Eur J Nucl Med; 1998 May 01; 25(5):481-90. PubMed ID: 9575243
    [Abstract] [Full Text] [Related]

  • 18. [3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreas.
    Pélaprat D, Zajac JM, Gacel G, Durieux C, Morgat JL, Sasaki A, Roques BP.
    Life Sci; 1985 Dec 30; 37(26):2483-90. PubMed ID: 3001463
    [Abstract] [Full Text] [Related]

  • 19. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
    Fourmy D, Lopez P, Poirot S, Jimenez J, Dufresne M, Moroder L, Powers SP, Vaysse N.
    Eur J Biochem; 1989 Nov 06; 185(2):397-403. PubMed ID: 2583188
    [Abstract] [Full Text] [Related]

  • 20. [3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors.
    Durieux C, Corringer PJ, Bergeron F, Roques BP.
    Eur J Pharmacol; 1989 Sep 13; 168(2):269-70. PubMed ID: 2606153
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.